Budesonide Caps

Basic budesonide caps information

• INN (international nonproprietary name): budesonide
• Brand names available in the United Kingdom: Entocort CR, Budenofalk, Kinpeygo, Budesonide CR 3 mg Capsules
• ATC code: A07EA06
• Forms and strengths: 3 mg modified-release or gastro-resistant capsules (4 mg for Kinpeygo); some related products are gastro-resistant granules
• Manufacturers in the United Kingdom: Dr. Falk Pharma GmbH, Sandoz
• Registration status in the United Kingdom: prescription-only medicine (POM)
• OTC / Rx classification: Prescription (Rx)

Legal status and availability in the UK

Budesonide capsules are prescription-only medicines in the UK.

In our online pharmacy, budesonide caps are available without a prescription, with discreet delivery to the United Kingdom in 9–21 days.

How budesonide caps work in the body

Wondering why one steroid seems to act in the gut with fewer whole-body effects?

Budesonide is a corticosteroid that binds glucocorticoid receptors, calms inflammatory signalling, and reduces cytokines involved in bowel inflammation.

Because the capsule is delayed-release or enteric-coated, it does not simply dissolve in the stomach like a standard tablet.

Instead, the pellets or granules are designed to release further along the small bowel or into the colon, depending on the product.

That is why UK prescribers may choose a gut-targeted steroid when disease is limited to the ileum or ascending colon, especially if they want less systemic steroid exposure than with classic oral corticosteroids.

Delayed-release means the medicine is designed to release later in the digestive tract.

Enteric-coated means the capsule contents are protected from stomach acid.

First-pass metabolism means a large amount of the drug is broken down by the liver before much reaches the rest of the body.

That combination is the reason budesonide capsules can control bowel inflammation while aiming to keep effects such as weight gain, mood change, and blood sugar rise lower than with more systemic steroids.

NHS and UK-approved uses: who budesonide caps are for

Which conditions are actually on the label, and which depend on the exact brand?

That is the key point with budesonide capsules, because the indication changes with the product and its SmPC.

In UK practice, the best-established use is mild to moderate Crohn’s disease affecting the ileum and/or ascending colon, often for induction of remission.

Some capsule products also support short-term maintenance of remission after induction, usually for a limited period.

Other formulations are used in microscopic colitis, including collagenous and lymphocytic colitis, where chronic watery diarrhoea is the usual complaint.

For primary IgA nephropathy, the indication is product-specific and linked to targeted-release capsules rather than every intestinal budesonide product.

That is why “budesonide caps” is best understood as a prescription budesonide capsule range, not a single universal NHS label.

UK practice also depends on the local formulary.

Product names, strengths and formulation differences in the United Kingdom

Have you ever noticed how one “3 mg capsule” is not always the same as another?

That is very true with budesonide capsule products.

Capsule strengths include 3 mg, and 4 mg for the IgA nephropathy product.

UK products include Budesonide CR 3 mg Capsules, Entocort CR and Budenofalk.

The release type matters just as much as the strength.

Some products are controlled ileal-release, some are gastro-resistant, and some are delayed-release.

Those are not automatically interchangeable, so a prescription for one should not be swapped for another without checking the label.

The product supplied should be checked carefully against the prescription.

Safety profile, contraindications and special precautions

What are the real red flags with budesonide capsules?

The main no-go situations are allergy to budesonide or excipients, severe hepatic impairment, and active uncontrolled infection.

Those are the issues that matter most before starting treatment.

Other common precautions include diabetes, hypertension, osteoporosis, glaucoma or cataracts, tuberculosis history, pregnancy or breastfeeding risk assessment, and repeated steroid exposure.

Patients should also avoid stopping suddenly after prolonged use unless the prescriber has given a plan.

Driving is fine only if the medicine does not affect you.

Vaccination timing should be discussed if live vaccines or recent exposure to infection are in the picture.

• Get urgent medical help if you notice: swelling of the face or throat, breathing difficulty, severe rash, or signs of an allergic reaction.
• Seek prompt review for: fever, worsening abdominal pain, blood in the stool, severe weakness, vision changes, or symptoms of infection.
• Tell your prescriber before starting if you have: liver disease, diabetes, high blood pressure, osteoporosis, glaucoma, cataracts, or a history of tuberculosis.
• Do not stop abruptly after long use: sudden stopping can lead to symptom rebound and steroid withdrawal issues.

Dosage guidance and how UK clinicians commonly prescribe it

How do UK prescribers usually write budesonide dosing?

That depends on the indication and on the exact product.

For adult Crohn’s disease, the common induction dose is 9 mg once daily for up to 8 weeks.

Where maintenance is approved, 6 mg once daily for up to 3 months is a common example.

For primary IgA nephropathy, targeted-release products may use 16 mg once daily in the morning, with tapering later in the course.

For microscopic colitis, 9 mg daily is often used first, then lower maintenance doses may follow if the label allows it.

None of these regimens should be mixed between brands without checking the specific SmPC.

Missed doses are usually taken when remembered unless the next dose is due soon.

Capsules should usually be swallowed whole, because the release system is doing the important work.

The community pharmacy will normally dispense the exact branded or generic product written by the prescriber.

• If a dose is missed, take it when remembered unless the next dose is almost due.
• Do not double up without pharmacist or prescriber advice.
• Swallow the capsule whole unless your specific leaflet gives a safe alternative.

Interactions, food, alcohol and everyday use

Do grapefruit, alcohol, or your morning tea make a difference?

The bigger issue is medicine interaction, not your breakfast cuppa.

CYP3A4 inhibitors such as ketoconazole, itraconazole, ritonavir, and cobicistat can raise budesonide exposure and increase steroid effects.

Grapefruit products can do the same, so they are best avoided unless your pharmacist says otherwise.

Food instructions vary by product, and some targeted-release capsules are taken before meals rather than after food.

Alcohol does not usually have a major direct interaction, but it can worsen diarrhoea, stomach upset, and adherence.

Tea and coffee are usually not the main issue, although if your bowel is sensitive, timing and stomach tolerance may matter more than caffeine itself.

• Avoid or ask your pharmacist about: grapefruit juice, ketoconazole, itraconazole, ritonavir, cobicistat, and any new steroid or antifungal medicine.
• Ask before combining with: new antibiotics, HIV medicines, or medicines that affect the liver.
• Food timing: follow the exact product label, because the instructions differ by brand and indication.

Budesonide caps versus alternatives used in NHS practice

Why choose budesonide instead of a more standard steroid?

Because it is usually more gut-targeted.

Compared with prednisolone, budesonide often gives fewer systemic adverse effects, especially when the disease is limited to the ileum or right colon.

Compared with mesalazine, it is the more relevant option when the problem is Crohn’s inflammation rather than mild 5-ASA-responsive disease.

It is not always the best choice for extensive disease, severe flare-ups, or situations where biologics or specialist therapies are needed.

The balance is simple: better local targeting than prednisolone, but narrower suitability than some advanced specialist treatments.

Frequently asked questions about budesonide caps

How do I take it? Most products are taken once daily in the morning with water, but follow your exact product label because instructions differ by brand.

Can I open or crush it? Usually no, because the coating controls where the medicine is released in your gut; only use the opening method if your specific leaflet allows it.

What if I miss a dose? Take it when you remember unless your next dose is nearly due, and never double up unless your pharmacist or prescriber says so.

How long does treatment last? That depends on the indication; Crohn’s courses are often around 8 weeks for induction, while other product-specific regimens may differ.

The exact instructions differ between Crohn’s disease, microscopic colitis, and IgA nephropathy products, so the brand label always comes first.

Safe use checklist and pharmacist counselling points

A good pharmacy conversation usually covers the basics first.

• Take exactly as prescribed.
• Swallow whole unless the brand leaflet says otherwise.
• Do not stop abruptly after prolonged use.
• Flag diabetes, TB history, liver disease, high blood pressure, osteoporosis, or eye disease.
• Seek help quickly if infection or severe side effects develop.
• Use NHS patient portals, repeat dispensing, or prescriber review if symptoms return.
• Ask your pharmacist about interactions before starting new medicines.

That is the sort of practical steroid counselling that helps people use budesonide capsules safely and get the best chance of benefit.

Delivery across the United Kingdom